Chimeric antigen receptor (CAR) T-cell therapy as a treatment option for patients with B-cell lymphomas: perspectives on the therapeutic potential of Axicabtagene ciloleucel

por Viardot, Andreas, Wais, Verena, Sala, Elisa, Koerper, Sixten
Publicado 2019

Concepts in immuno-oncology: tackling B cell malignancies with CD19-directed bispecific T cell engager therapies

por Viardot, Andreas, Locatelli, Franco, Stieglmaier, Julia, Zaman, Faraz, Jabbour, Elias
Publicado 2020

Oncological outcome and recurrence pattern analysis after involved-field irradiation in combination with rituximab for early-stage nodal and extranodal follicular lymphoma

por König, Laila, Herfarth, Klaus, Hörner-Rieber, Juliane, Dietrich, Sascha, Wiegel, Thomas, Debus, Jürgen, Viardot, Andreas
Publicado 2020

Suppressor of cytokine signaling 1 gene mutation status as a prognostic biomarker in classical Hodgkin lymphoma

por Lennerz, Jochen K., Hoffmann, Karl, Bubolz, Anna-Maria, Lessel, Davor, Welke, Claudia, Rüther, Nele, Viardot, Andreas, Möller, Peter
Publicado 2015

COVID-19 Vaccination after Allogeneic Stem Cell Transplantation: Real Word Data on Safety and Efficacy. a Single Center Experience.

por Neagoie, Adela, Sommer, Charlotte, Gantner, Andrea, Wais, Verena, Schnell, Jacqueline, Simon, Hannah, Viardot, Andreas, Döhner, Hartmut, Bunjes, Donald, Sala, Elisa
Publicado 2021

Targetable alterations in primary extranodal diffuse large B‐cell lymphoma

por Weissinger, Stephanie E., Dugge, Rucha, Disch, Miriam, Barth, Thomas F., Bloehdorn, Johannes, Zahn, Malena, Marienfeld, Ralf, Viardot, Andreas, Möller, Peter
Publicado 2022

Loss-of-function but not dominant-negative intragenic IKZF1 deletions are associated with an adverse prognosis in adult BCR-ABL-negative acute lymphoblastic leukemia

por Kobitzsch, Benjamin, Gökbuget, Nicola, Schwartz, Stefan, Reinhardt, Richard, Brüggemann, Monika, Viardot, Andreas, Wäsch, Ralph, Starck, Michael, Thiel, Eckhard, Hoelzer, Dieter, Burmeister, Thomas
Publicado 2017

Therapy of nodal Follicular Lymphoma (WHO grade 1/2) in clinical stage I/II using response adapted Involved Site Radiotherapy in combination with Obinutuzumab (Gazyvaro) - GAZAI Tr...

por König, Laila, Dreyling, Martin, Dürig, Jan, Engelhard, Marianne, Hohloch, Karin, Viardot, Andreas, Witzens-Harig, Mathias, Kieser, Meinhard, Klapper, Wolfram, Pott, Christiane, Herfarth, Klaus
Publicado 2019

S114: OUTCOME OF OLDER PATIENTS (>55 YRS) WITH NEWLY DIAGNOSED PH/BCR:ABL POSITIVE ALL PROSPECTIVELY TREATED ACCORDING TO PEDIATRIC-BASED, AGE-ADAPTED GMALL PROTOCOLS

por Lang, Fabian, Pfeifer, Heike, Raffel, Simon, Fiedler, Walter, Hanoun, Maher, Hänel, Mathias, Spriewald, Bernd, Viardot, Andreas, Vucinic, Vladan, Serve, Hubert, Hoelzer, Dieter, Gökbuget, Nicola
Publicado 2023

Thromboembolism after Astra Zeneca COVID-19 vaccine: Not always PF4- antibody mediated

por d’Almeida, Sascha, Markovic, Sinisa, Hermann, Patrick, Bracht, Hendrik, Peifer, Johannes, Ettrich, Thomas J., Imhof, Armin, Zhou, Shaoxia, Weiss, Manfred, Viardot, Andreas, Rottbauer, Wolfgang, Dahme, Tillman
Publicado 2023

A phase II study of the PI3K inhibitor copanlisib in combination with the anti-CD20 monoclonal antibody rituximab for patients with marginal zone lymphoma: treatment rationale and...

por Grunenberg, Alexander, Kaiser, Lisa M., Woelfle, Stephanie, Schmelzle, Birgit, Viardot, Andreas, Möller, Peter, Barth, Thomas F. E., Muche, Rainer, Dreyhaupt, Jens, Raderer, Markus, Kiesewetter, Barbara, Buske, Christian
Publicado 2021

90-yttrium-ibritumomab tiuxetan as first-line treatment for follicular lymphoma: updated efficacy and safety results at an extended median follow-up of 9.6 years

por Rieger, Kathrin, De Filippi, Rosaria, Lindén, Ola, Viardot, Andreas, Hess, Georg, Lerch, Kristina, Neumeister, Peter, Stroux, Andrea, Peuker, Caroline A., Pezzutto, Antonio, Pinto, Antonello, Keller, Ulrich, Scholz, Christian W.
Publicado 2022

Prognostic value of low-level MRD in adult acute lymphoblastic leukemia detected by low- and high-throughput methods

por Kotrová, Michaela, Koopmann, Johannes, Trautmann, Heiko, Alakel, Nael, Beck, Joachim, Nachtkamp, Kathrin, Steffen, Björn, Raffel, Simon, Viardot, Andreas, Wethmar, Klaus, Darzentas, Nikos, Baldus, Claudia D., Gökbuget, Nicola, Brüggemann, Monika
Publicado 2022

U-DCS: characterization of the first permanent human dendritic sarcoma cell line

por Mellert, Kevin, Benckendorff, Julian, Leithäuser, Frank, Zimmermann, Katarzyna, Wiegand, Peter, Frascaroli, Giada, Buck, Michaela, Malaise, Muriel, Hartmann, Gunther, Barchet, Winfried, Fürst, Daniel, Mytilineos, Joannis, Mayer-Steinacker, Regine, Viardot, Andreas, Möller, Peter
Publicado 2020

Targeting CD19 in diffuse large B‐cell lymphoma: An expert opinion paper

por Bailly, Sarah, Cartron, Guillaume, Chaganti, Sridhar, Córdoba, Raul, Corradini, Paolo, Düll, Johannes, Ferrarini, Isacco, Osborne, Wendy, Rosenwald, Andreas, Sancho, Juan‐Manuel, Tilly, Hervé, Van Den Neste, Eric, Viardot, Andreas, Visco, Carlo
Publicado 2022

The mTOR Inhibitor Temsirolimus Added to Rituximab Combined With Dexamethasone, Cytarabine, and Cisplatinum (R-DHAP) for the Treatment of Patients With Relapsed or Refractory DLBCL...

por Witzens-Harig, Mathias, Viardot, Andreas, Keller, Ulrich, Wosniok, Julia, Deuster, Oliver, Klemmer, Jennifer, Geueke, Anne-Marie, Meißner, Julia, Ho, Anthony D., Atta, Johannes, Marks, Reinhard, La Rosée, Paul, Buske, Christian, Dreyling, Martin H., Hess, Georg
Publicado 2021

Safety of AFM11 in the treatment of patients with B-cell malignancies: findings from two phase 1 studies

por Topp, Max, Dlugosz-Danecka, Monika, Skotnicki, Aleksander B., Salogub, Galina, Viardot, Andreas, Klein, Andreas K., Hess, Georg, Michel, Christian S., Grosicki, Sebastian, Gural, Alex, Schwarz, Sylvia E., Pietzko, Kerstin, Gärtner, Ulrike, Strassz, András, Alland, Leila, Mayer, Jiri
Publicado 2023

Potential clinical implications of BRAF mutations in histiocytic proliferations

por Bubolz, Anna-Maria, Weissinger, Stephanie E., Stenzinger, Albrecht, Arndt, Annette, Steinestel, Konrad, Brüderlein, Silke, Cario, Holger, Lubatschofski, Anneli, Welke, Claudia, Anagnostopoulos, Ioannis, Barth, Thomas F. E., Beer, Ambros J., Möller, Peter, Gottstein, Martin, Viardot, Andreas, Lennerz, Jochen K.
Publicado 2014

P355: FAVORABLE OUTCOME OF PHILADELPHIA-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA WITH IMATINIB, DOSE-REDUCED INDUCTION FOLLOWED BY ALLOGENEIC STEM CELL TRANSPLANTATION –RESULTS FROM T...

por Pfeifer, Heike, Lang, Fabian, Fiedler, Walter, Stelljes, Matthias, Schneller, Folker, Steffen, Björn, Böll, Boris, Viardot, Andreas, Faul, Christoph, Lars Teichmann, Lino, Poeck, Hendrik, Westermann, Jörg, Schaefer-Eckart, Kerstin, Heinicke, Thomas, Serve, Hubert, Brüggemann, Monika, Schwartz, Stefan, Burmeister, Thomas, Gökbuget, Nicola
Publicado 2023

Phase I dose escalation study of BI 836826 (CD37 antibody) in patients with relapsed or refractory B-cell non-Hodgkin lymphoma

por Kroschinsky, Frank, Middeke, Jan Moritz, Janz, Martin, Lenz, Georg, Witzens-Harig, Mathias, Bouabdallah, Reda, La Rosée, Paul, Viardot, Andreas, Salles, Gilles, Kim, Seok Jin, Kim, Tae Min, Ottmann, Oliver, Chromik, Joerg, Quinson, Anne-Marie, von Wangenheim, Ute, Burkard, Ute, Berk, Andreas, Schmitz, Norbert
Publicado 2020